Zimmer Biomet Holdings, Inc. (ZBH) Stock
ZBH Key Statistics
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
CEO: Ivan Tornos. Company website
ZBH — Frequently Asked Questions
What is the ZBH stock price today?
Zimmer Biomet Holdings, Inc. (ZBH) trades at $107.47, up 0.14% on the day, as of Nov 12, 2026 09:31 UTC.
What is Zimmer Biomet Holdings, Inc.'s market cap?
Zimmer Biomet Holdings, Inc. has a market capitalisation of $20.50B, calculated from the live ZBH share price and shares outstanding.
What is the P/E ratio of ZBH?
ZBH trades at a trailing P/E of 27.18, from earnings per share of $3.95 over the last twelve months.
How much revenue does Zimmer Biomet Holdings, Inc. make?
Zimmer Biomet Holdings, Inc. generated revenue of $8.57B over the trailing twelve months, which puts the stock at 2.39 times sales.
Does ZBH pay a dividend?
Yes. Zimmer Biomet Holdings, Inc. pays a dividend yielding 1.07% on the current share price.
What is the 52-week range for ZBH?
ZBH has traded between $79.12 and $112.55 over the past 52 weeks, and the last price is 4.5% below that high.
Is Zimmer Biomet Holdings, Inc. profitable?
Yes. Zimmer Biomet Holdings, Inc. keeps 8.95% of revenue as net income over the trailing twelve months.
What is the analyst price target for ZBH?
Wall Street analysts rate ZBH Hold, with an average price target of $109.11, 1.5% above the current price.
What sector is Zimmer Biomet Holdings, Inc. in?
Zimmer Biomet Holdings, Inc. is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US.
Who is the CEO of Zimmer Biomet Holdings, Inc.?
Ivan Tornos is the chief executive of Zimmer Biomet Holdings, Inc., which employs 17,000 people.
Where can I track ZBH in real time?
QFI Terminal shows ZBH with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See ZBH live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ZBH in Terminal See plans